KPV Peptide: Preclinical Inflammatory Signaling

Research and Quality-Verified Lyophilized Format

KPV is a short synthetic tripeptide extensively used in pre-clinical research to investigate intracellular anti-inflammatory signaling, PepT1-mediated uptake in intestinal cells, and suppression of pro-inflammatory cascades in epithelial and immune models. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications.

Engineered solely for preclinical investigations, each batch of KPV undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification.

Scientific Overview

KPV influences key inflammatory pathways in research settings, including inhibition of NF-κB activation and reduction of cytokine production. Preclinical investigations demonstrate KPV’s potential effects in the following areas:

• Suppression of NF-κB signaling and pro-inflammatory cytokine expression
• Modulation of epithelial barrier function in intestinal models
• Reduction of inflammatory infiltrates in colitis models
• Influence on immune cell responses in mucosal tissues
• Support for studies on PepT1-dependent peptide uptake in the inflamed colon

Research-Referenced Functional Attributes (Based on existing preclinical and literature data—not intended as claims of therapeutic use)

• Inhibition of NF-κB activation leading to decreased pro-inflammatory cytokine synthesis in colonic epithelial and immune cells (DOI: 10.1053/j.gastro.2007.09.038)
• PepT1-mediated uptake into intestinal cells enabling intracellular anti-inflammatory effects in colitis models (DOI: 10.1053/j.gastro.2007.09.038)
• Attenuation of inflammatory responses and reduced colitis incidence observed in DSS- and TNBS-induced murine models
• Suppression of p65RelA nuclear import in airway epithelium models, potentially via importin interactions
• Reduction of inflammatory infiltrates and MPO activity in murine IBD models
• Examination of anti-inflammatory actions independent of MC1R signaling in certain peritonitis models

Why Researchers Choose Our KPV

For laboratories requiring dependable KPV research peptides, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

• Purity ≥99% by HPLC
• Structural identity via mass spectrometry
• Third-party Certificate of Analysis (COA) available per lot

For Research Use Only. Not for human use.

Explore our testing protocols in About Peptides > Rigorous Testing.